Transcatheter Pulmonary Valve Market Growth & Trends
The global transcatheter pulmonary valve market size is expected to reach USD 100.6 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 . The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.
In 2023, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.
However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.
Transcatheter Pulmonary Valve Market Report Highlights
- Pulmonary stenosis dominated the market and accounted for a market share of 43.1% in 2023. TPV operations are less invasive in nature compared to open-heart surgery.
- In 2023, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing transcatheter pulmonary valve market during the forecast period
- Some of the key players are Boston Scientific Corporation, Braile Biomédica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, and VENUS MEDTECH.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Transcatheter Pulmonary Valve Market Variables, Trends, & Scope
Chapter 4. Transcatheter Pulmonary Valve Market: Application Estimates & Trend Analysis
Chapter 5. Transcatheter Pulmonary Valve Market: Technology Estimates & Trend Analysis
Chapter 6. Transcatheter Pulmonary Valve Market: End Use Estimates & Trend Analysis
Chapter 7. Transcatheter Pulmonary Valve Market: Raw Material Estimates & Trend Analysis
Chapter 8. Transcatheter Pulmonary Valve Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
Companies Mentioned
- Boston Scientific Corporation
- Braile Biomedica
- Artivion, Inc
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc
- LivaNova PLC
- Medtronic
- Venus Medtech
- Lepu Medical Technology
- Jude Medical Inc
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 69.7 Million |
| Forecasted Market Value ( USD | $ 100.6 Million |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
